Additionally, in colorectal cancer cells with p53 mutations, CDC25C was shown to be involved in irinotecan-induced radiosensitization via the ATM/CHK/CDC25C/CDC2 pathway 79. This evidence concerns the gene CDC25C and colorectal cancer.